| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |